GlassScriptPhysician profile
Shahid U Rehman
NPI 1104084458
$8,400.27
in general payments reported to CMS, 2019-2025
45 companies · $962 in 2025
The $962 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,280 · 2020: $438 · 2021: $834 · 2022: $1,234 · 2023: $2,409 · 2024: $1,243 · 2025: $962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,262 · Travel and Lodging: $342 · Education: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.26 |
| Travel and Lodging | $341.97 |
| Education | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,592.66 | 2021-2025 | |
| Ucb, INC. | $890.85 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Emd Serono, INC. | $522.57 | 2019-2025 | Mavenclad |
| Mdd US Operations, LLC | $463.11 | 2019-2023 | Myobloc, Gocovri |
| Neurocrine Biosciences, INC. | $457.78 | 2019-2025 | Ingrezza, Ongentys |
| Allergan, INC. | $457.47 | 2019-2022 | |
| Sk Life Science, INC. | $311.22 | 2022-2025 | Xcopri |
| Genzyme Corporation | $296.17 | 2019-2023 | |
| Pfizer INC. | $283.12 | 2019-2025 | |
| Lilly USA, LLC | $180.54 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Boston Scientific Corporation | $145.53 | 2020 | |
| Csl Behring | $145.08 | 2019-2023 | Hizentra, Privigen |
| Amneal Pharmaceuticals LLC | $127.84 | 2021-2023 | Rytary |
| Integra Lifesciences Corporation | $110.80 | 2021-2023 | Codman Certas, Codman Hakim, Cusa Clarity |
| Biohaven Pharmaceutical Holding Company LTD. | $103.18 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahid Rehman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.